Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns

Stem Cells International

Volumn 2016, Issue , 2016, Pages

  Elahi, Kourosch C ^a   Klein, Gerd ^a   Avci Adali, Meltem ^b   Sievert, Karl D ^c   Macneil, Sheila ^d   Aicher, Wilhelm K ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c St Johanns Spital   (Austria)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CELL SURFACE PROTEIN; DICKKOPF 1 PROTEIN; MEMBRANE ANTIGEN; NERVE GROWTH FACTOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTOME;

ANTIGEN EXPRESSION; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL EXPANSION; CELL ISOLATION; CELL PROLIFERATION; CELL SELF-RENEWAL; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; OSTEOBLAST; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 84953215638     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2016/5646384     Document Type: Review

References (72)

1. A. J. Friedenstein, R. K. Chailakhjan, and K. S. Lalykina, The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, Cell and Tissue Kinetics, vol. 3, no. 4, pp. 393-403, 1970.
2. A. J. Friedenstein, J. F. Gorskaja, and N. N. Kulagina, Fibroblast precursors in normal and irradiated mouse hematopoietic organs, Experimental Hematology, vol. 4, no. 5, pp. 267-274, 1976.
3. S. Wakitani, T. Goto, S. J. Pineda et al., Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage, The Journal of Bone and Joint Surgery-American Volume, vol. 76, no. 4, pp. 579-592, 1994.
4. E. J. Schwarz, G. M. Alexander, D. J. Prockop, and S. A. Azizi, Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease, Human GeneTherapy, vol. 10, no. 15, pp. 2539-2549, 1999.
5. H. A. Awad, D. L. Butler, G. P. Boivin et al., Autologous mesenchymal stem cell-mediated repair of tendon, Tissue Engineering, vol. 5, no. 3, pp. 267-277, 1999.
6. M. K. Majumdar, M. A. Thiede, J. D. Mosca, M. Moorman, and S. L. Gerson, Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells, Journal of Cellular Physiology, vol. 176, no. 1, pp. 57-66, 1998.
7. M. F. Pittenger, A. M. Mackay, S. C. Beck et al., Multilineage potential of adult human mesenchymal stem cells, Science, vol. 284, no. 5411, pp. 143-147, 1999.
8. C. M. Kolf, E. Cho, and R. S. Tuan, Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation, Arthritis Research and Therapy, vol. 9, no. 1, article 204, 2007.
9. A. I. Caplan, Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics, Tissue Engineering, vol. 11, no. 7-8, pp. 1198-1211, 2005.
10. H. Shenghui, D. Nakada, and S. J. Morrison, Mechanisms of stem cell self-renewal, Annual Review of Cell and Developmental Biology, vol. 25, pp. 377-406, 2009.
11. W. Wagner, P. Horn, M. Castoldi et al., Replicative senescence of mesenchymal stem cells: a continuous and organized process, PLoS ONE, vol. 3, no. 5, Article ID e2213, 2008.
12. A. Muraglia, R. Cancedda, and R. Quarto, Clonal mesenchymal progenitors from human bonemarrow differentiate in vitro according to a hierarchical model, Journal of Cell Science, vol. 113, no. 7, pp. 1161-1166, 2000.
13. P. Bianco, X. Cao, P. S. Frenette et al., The meaning, the sense and the significance: translating the science of mesenchymal stem cells intomedicine, Nature Medicine, vol. 19, no. 1, pp. 35-42, 2013.
14. L. da Silva Meirelles, P. C. Chagastelles, and N. B. Nardi, Mesenchymal stem cells reside in virtually all post-natal organs and tissues, Journal of Cell Science, vol. 119, part 11, pp. 2204-2213, 2006.
15. P. De Coppi, A. Callegari, A. Chiavegato et al., Amniotic fluid and bone marrow derived mesenchymal stem cells can be converted to smoothmuscle cells in the cryo-injured rat bladder and prevent compensatory hypertrophy of surviving smooth muscle cells, Journal of Urology, vol. 177, no. 1, pp. 369-376, 2007.
16. P. S. Int Anker, S. A. Scherjon, C. K.-V. der Keur et al., Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta, Stem Cells, vol. 22, no. 7, pp. 1338-1345, 2004.
17. O. K. Lee, T. K. Kuo, W.-M. Chen, K.-D. Lee, S.-L. Hsieh, and T.-H. Chen, Isolation of multipotent mesenchymal stem cells from umbilical cord blood, Blood, vol. 103, no. 5, pp. 1669-1675, 2004.
18. K. Bieback, S. Kern, H. Kluter, and H. Eichler, Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood, Stem Cells, vol. 22, no. 4, pp. 625-634, 2004.
19. C. Limbert, R. Ebert, T. Schilling et al., Functional signature of human islet-derived precursor cells compared to bone marrowderived mesenchymal stem cells, Stem Cells and Development, vol. 19, no. 5, pp. 679-691, 2010.
20. D. T. Covas, R. A. Panepucci, A. M. Fontes et al., Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts, Experimental Hematology, vol. 36, no. 5, pp. 642-654, 2008.
21. O. Parolini, F. Alviano, G. P. Bagnara et al., Concise review: isolation and characterization of cells from human term placenta: outcome of the First InternationalWorkshop on Placenta Derived StemCells, StemCells, vol. 26, no. 2, pp. 300-311, 2008.
22. G. Pilz, C. Ulrich, T. Abruzzese et al., Human term placentaderived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells, Stem Cells and Development, vol. 20, pp. 635-646, 2010.
23. M. Dominici, K. Le Blanc, I. Muller et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
24. M. Crisan, S. Yap, L. Casteilla et al., A perivascular origin for mesenchymal stem cells in multiple human organs, Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
25. E. Schipani and H. M. Kronenberg, Adult Mesenchymal Stem Cells, Harvard Stem Cell Institute, Cambridge, Mass, USA, 2008.
26. A. C. W. Zannettino, S. Paton, A. Arthur et al., Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo, Journal of Cellular Physiology, vol. 214, no. 2, pp. 413-421, 2008.
27. P. A. Zuk, M. Zhu, H. Mizuno et al., Multilineage cells from human adipose tissue: implications for cell-based therapies, Tissue Engineering, vol. 7, no. 2, pp. 211-228, 2001.
28. J. B. Mitchell, K. McIntosh, S. Zvonic et al., Immunophenotype of human adipose-derived cells: temporal changes in stromalassociated and stemcell-associated markers, StemCells, vol. 24, no. 2, pp. 376-385, 2006.
29. W. K. Aicher, H.-J. Buhring, M. Hart, B. Rolauffs, A. Badke, and G. Klein, Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells-potential and pitfalls, Advanced Drug Delivery Reviews, vol. 63, no. 4, pp. 342-351, 2011.
30. V. L. Battula, S. Treml, P. M. Bareiss et al., Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1, Haematologica, vol. 94, no. 2, pp. 173-184 (2009).
31. C. De Bari, F. DellAccio, P. Tylzanowski, and F. P. Luyten, Multipotent mesenchymal stem cells from adult human synovial membrane, Arthritis and Rheumatism, vol. 44, no. 8, pp. 1928-1942, 2001.
32. G. P. Dowthwaite, J. C. Bishop, S. N. Redman et al., The surface of articular cartilage contains a progenitor cell populations, Journal of Cell Science, vol. 117, no. 6, pp. 889-897, 2004.
33. K. Benz, C. Stippich, C. Freudigmann, J. A. Mollenhauer, and W. K. Aicher, Maintenance of stem cell features of cartilage cell sub-populations during in vitro propagation, Journal of Translational Medicine, vol. 11, article 27, 2013.
34. A. I. Caplan, AllMSCs are pericytes? Cell Stem Cell, vol. 3, no. 3, pp. 229-230, 2008.
35. A. Wilson and A. Trumpp, Bone-marrow haematopoieticstem-cell niches, Nature Reviews Immunology, vol. 6, no. 2, pp. 93-106, 2006.
36. J. F. Smith, P. Yango, E. Altman et al., Testicular niche required for human spermatogonial stem cell expansion, Stem Cells Translational Medicine, vol. 3, no. 9, pp. 1043-1054, 2014.
37. K. Warstat, D. Meckbach, M. Weis-Klemm et al., TGF-β enhances the integrin α2β1-mediated attachment of mesenchymal stem cells to type i collagen, Stem Cells and Development, vol. 19, no. 5, pp. 645-656, 2010.
38. S. Danmark, A. Finne-Wistrand, A.-C. Albertsson, M. Patarroyo, and K. Mustafa, Integrin-mediated adhesion of human mesenchymal stem cells to extracellular matrix proteins adsorbed to polymer surfaces, Biomedical Materials, vol. 7, no. 3, Article ID 035011, 2012.
39. R. F. Wynn, C. A. Hart, C. Corradi-Perini et al., Asmall proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promotingmigration to bone marrow, Blood, vol. 104, no. 9, pp. 2643-2645, 2004.
40. J. M. Karp and G. S. Leng Teo, Mesenchymal stemcell homing: the devil is in the details, Cell Stem Cell, vol. 4, no. 3, pp. 206-216, 2009.
41. G. Y. Rochefort, B. Delorme, A. Lopez et al., Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia, Stem Cells, vol. 24, no. 10, pp. 2202-2208, 2006.
42. J. M. Fox, G. Chamberlain, B. A. Ashton, and J. Middleton, Recent advances into the understanding ofmesenchymal stem cell trafficking, British Journal of Haematology, vol. 137, no. 6, pp. 491-502, 2007.
43. G. S. L. Teo, Z. Yang, C. V. Carman, J. M. Karp, and C. P. Lin, Intravital imaging of mesenchymal stem cell trafficking and association with platelets and neutrophils, Stem Cells, vol. 33, no. 1, pp. 265-277, 2014.
44. A. G. Via, A. Frizziero, and F. Oliva, Biological properties of mesenchymal Stem Cells from different sources, Muscles, Ligaments and Tendons Journal, vol. 2, no. 3, pp. 154-162, 2012.
45. H.-J. Buuhring, V. L. Battula, S. Treml, B. Schewe, L. Kanz, and W. Vogel, Novelmarkers for the prospective isolation of human MSC, Annals of the New York Academy of Sciences, vol. 1106, pp. 262-271, 2007.
46. E. Jones, A. English, S. M. Churchman et al., Large-scale extraction and characterization of CD271+ multipotential stromal cells from trabecular bone in health and osteoarthritis: implications for bone regeneration strategies based on uncultured or minimally cultured multipotential stromal cells, Arthritis and Rheumatism, vol. 62, no. 7, pp. 1944-1954, 2010.
47. R. H. Lee, B. Kim, I. Choi et al., Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue, Cellular Physiology and Biochemistry, vol. 14, no. 4-6, pp. 311-324, 2004.
48. J. A. Jeong, S. H. Hong, E. J. Gang et al., Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray, Stem Cells, vol. 23, no. 4, pp. 584-593, 2005.
49. M. Secco, Y. B. Moreira, E. Zucconi et al., Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different fromblood, Stem Cell Reviews and Reports, vol. 5, no. 4, pp. 387-401, 2009.
50. C. Ulrich, T. Abruzzese, J. K. Maerz et al., Human placentaderived CD146-positive mesenchymal stromal cells display a distinct osteogenic differentiation potential, Stem Cells and Development, vol. 24, no. 13, pp. 1558-1569, 2015.
51. S. Barlow, G. Brooke, K. Chatterjee et al., Comparison of human placenta-and bone marrow-derived multipotent mesenchymal stem cells, Stem Cells and Development, vol. 17, no. 6, pp. 1095-1107, 2008.
52. M.-S. Tsai, S.-M. Hwang, K.-D. Chen et al., Functional network analysis of the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow, Stem Cells, vol. 25, no. 10, pp. 2511-2523, 2007.
53. G. A. Pilz, C. Ulrich, M. Ruh et al., Human term placentaderived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells, Stem Cells and Development, vol. 20, no. 4, pp. 635-646, 2011.
54. T. Takarada, E. Hinoi, R. Nakazato et al., An analysis of skeletal development in osteoblast-specific and chondrocyte-specific runt-related transcription factor-2 (Runx2) knockout mice, Journal of Bone and Mineral Research, vol. 28, no. 10, pp. 2064-2069, 2013.
55. C. Pendleton, Q. Li, D. A. Chesler, K. Yuan, H. Guerrero-Cazares, and A. Quinones-Hinojosa, Mesenchymal stem cells derived from adipose tissue vs bone marrow: in vitro comparison of their tropism towards gliomas, PLoS ONE, vol. 8, no. 3, Article ID e58198, 2013.
56. W. Vogel, F. Grunebach, C. A. Messam, L. Kanz, W. Brugger, and H.-J. Buhring, Heterogeneity among human bone marrowderived mesenchymal stem cells and neural progenitor cells, Haematologica, vol. 88, no. 2, pp. 126-133, 2003.
57. Y. Mabuchi, S. Morikawa, S. Harada et al., LNGFR(+), THY-1(+), VCAM-1(hi+) cells reveal functionally distinct subpopulations inmesenchymal stem cells, Stem Cell Reports, vol. 1, no. 2, pp. 152-165, 2013.
58. Y. Mabuchi, D. D. Houlihan, C. Akazawa, H. Okano, and Y. Matsuzaki, Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers, Stem Cells International, vol. 2013, Article ID 507301, 7 pages, 2013.
59. K. Sivasubramaniyan, A. Harichandan, S. Schumann et al., Prospective isolation of mesenchymal stem cells from human bone marrow using novel antibodies directed against Sushi domain containing 2, Stem Cells and Development, vol. 22, no. 13, pp. 1944-1954, 2013.
60. H. Li, R. Ghazanfari, D. Zacharaki et al., Low/negative expression of PDGFR-α identifies the candidate primary mesenchymal stromal cells in adult human bone marrow, Stem Cell Reports, vol. 3, no. 6, pp. 965-974, 2014.
61. S. Pinho, J. Lacombe, M. Hanoun et al., PDGFRα and CD51 mark human Nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion, The Journal of ExperimentalMedicine, vol. 210, no. 7, pp. 1351-1367, 2013.
62. S. Mendez-Ferrer, T. V. Michurina, F. Ferraro et al., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche, Nature, vol. 466, no. 7308, pp. 829-834, 2010.
63. B. Sacchetti, A. Funari, S. Michienzi et al., Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment, Cell, vol. 131, no. 2, pp. 324-336, 2007.
64. M. L. Hart, J. Brun, K. Lutz, B. Rolauffs, and W. K. Aicher, Do we need standarized, GMP-compliant cell culture procedures for pre-clinical in vitro studies involving mesenchymal stem/stromal cells? Journal of Tissue Science and Engineering, vol. 5, pp. 135-139, 2014.
65. N. Kim and S.-G. Cho, Clinical applications of mesenchymal stem cells, Korean Journal of Internal Medicine, vol. 28, no. 4, pp. 387-402, 2013.
66. Y. Wang, Z.-B. Han, Y.-P. Song, and Z. C. Han, Safety of mesenchymal stem cells for clinical application, Stem Cells International, vol. 2012, Article ID 652034, 4 pages, 2012.
67. A. M. Bailey, Balancing tissue and tumor formation in regenerativemedicine, Science TranslationalMedicine, vol. 4, no. 147, Article ID 147fs28, 2012.
68. F. Baron and R. Storb, Mesenchymal stromal cells: a new tool against graft-versus-host disease? Biology of Blood andMarrow Transplantation, vol. 18, no. 6, pp. 822-840, 2012.
69. M. Introna, G. Lucchini, E. Dander et al., Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients, Biology of Blood and Marrow Transplantation, vol. 20, no. 3, pp. 375-381, 2014.
70. M. Breitbach, T. Bostani, W. Roell et al., Potential risks of bone marrow cell transplantation into infarcted hearts, Blood, vol. 110, no. 4, pp. 1362-1369, 2007.
71. W. C. Hines, Y. Su, I. Kuhn, K. Polyak, and M. J. Bissell, Sorting out the FACS: a devil in the details, Cell Reports, vol. 6, no. 5, pp. 779-781, 2014.
72. G. A. Pilz, J. Braun, C. Ulrich et al., Human mesenchymal stromal cells express CD14 cross-reactive epitopes, Cytometry A, vol. 79, no. 8, pp. 635-645, 2011.